Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research

  • Post date May 8, 2022 — 13:23 Post Lock Login to View

Key Data Concepts:   
? These are the company names, stock quotes, topics, and entities related to this data.

000925 002014 002486 300322 Guotai Junan Securities Huangshan Novel Huizhou Speed Wireless Technology Jiangsu Hengrui Medicine Nanjing Pharmaceutical Shanghai Challenge Textile Company Limited Unittec Xiamen Amoytop Biotech Zhejiang Huahai Pharmaceutical Witness Layoffs, Downsizing Management Annual, Special Corporate Meeting Annual Report Research, Development Health, Beauty Product Pharmaceutical Credit, Debt Market, Exchange Securities Stocks Diseases, Conditions Cancer Epidemic Hospital Medicine Therapy Workplace Health, Safety Food, Drink Enthusiasm House, Home Small, Medium Enterprise Oncology Midsummer Health

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login



Related Data